Coryn Mayer says the healthcare system needs to improve if psilocybin therapy is to become a mainstream tool.
Vancouver biotechnology company Havn Life will export yield to UBC-based Delic Labs for quality control and testing.
The Vancouver-based company has a licence from Health Canada to test, sell, and distribute psychedelic substances.
Petter Grahl Johnstad of the University of Bergen says a bad psychedelics trip can be a way to confront personal demons.
Toronto-based Cybin plans to look at real time effects of ketamine on the brain.
A study in Argentina finds association between the use of psychedelic substances with positive mental health outcomes.